EIF2AK4 and Alzheimer disease: Ma et al. reported that conditional homozygous deletion of either of two different eIF2α kinases (Perk, Gcn2) in forebrain neurons improved spatial memory impairments in the APPswe/PSEN1dE9 mouse model of AD [14].